Ajanta Pharma has received a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The certificate was issued by MUFG Intime India Private Limited, the Registrar and Share Transfer Agent of the Company, confirming compliance with handling dematerialization requests.
Compliance Confirmation
Ajanta Pharma has been issued a certificate verifying compliance with SEBI (Depositories and Participants) Regulations. This certificate, received from MUFG Intime India Private Limited, pertains to Regulation 74(5) and covers the period ending December 31, 2025.
Details of the Certificate
The certificate confirms that all securities received for dematerialization during Q3 (October-December) of FY26 were duly processed and confirmed to the depositories. The certificate also confirms that the security certificates received were mutilated and cancelled after due verification by the depository participant.
Registrar and Transfer Agent
MUFG Intime India Private Limited, the Registrar and Share Transfer Agent, issued the certificate. They confirmed that securities were listed on the stock exchanges where the earlier issued securities are listed. The names of the depositories have been substituted in the register of members.
Source: BSE
